Disappearance of HBcAG in the liver is a clinically useful marker for discontinuation of lamivudine therapy in patients with chronic hepatitis B

✍ Scribed by Watanabe, H.; Izumi, N.; Simizu, M.; Noguchi, O.; Hoshino, Y.; Uchihara, M.; Miyake, S.; Sakai, T.; Enomoto, N.; Sato, C.

• Book ID: 122777118
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 172 KB
• Volume: 114
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(98)85533-9